Jean Francois Formela Insider Profile

4 Followers
Jean Francois Formela, Director, Ten Percent Owner at Horizon Therapeutics, holds 1.14M shares in Korro Bio (Ticker: KRRO), holds 7.29K shares in Intellia Therapeutics (Ticker: NTLA), holds 4.14M shares in Ikena Oncology (Ticker: IKNA).
tipranks
Jean Francois Formela

Jean Francois Formela
Horizon Therapeutics (HZNP)
Director, Ten Percent Owner

Ranked #95,494 out of 99,218 Corporate Insiders

Profitable Transactions

10%
1 out of 10 Profitable Transactions

Average Return

-52.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$136M
48.54%
31.52%
14.64%
5.23%
0.08% Others
A breakdown of Jean Francois Formela's holdings

Insider Roles

Korro Bio
(KRRO)
Director
Oruka Therapeutics
(ORKA)
Director, Ten Percent Owner
Exelixis
(EXEL)
Director
Ikena Oncology
(IKNA)
Director
+2 other positions
Roles that Jean Francois Formela holds in companies

Most Profitable Insider Trade

Stock:
Intellia Therapeutics
(NTLA)
Rating:Informative Sell
Date:Mar 22, 2018 - Mar 22, 2019
Return:+29.80%
The most profitable trade made by Jean Francois Formela

Jean Francois Formela's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
HZNP
Horizon Therapeutics
Mar 06, 2012
Informative Buy
3.00M
$428.95M
Intellia Therapeutics
Jun 16, 2022
Director
Uninformative Buy
$107.98K
Spero Therapeutics
Director
~TBIO
Translate Bio
Sep 14, 2021
Uninformative Sell
78.09M
$0.00
Ikena Oncology
Dec 14, 2021
Director
Informative Buy
2.00M
$7.13M
Korro Bio
Apr 23, 2024
Director
Uninformative Buy
999.99K
$66.14M
NXTM
NxStage Medical
$77.76M
EGLTQ
Egalet Corp
Feb 12, 2014
Informative Buy
500.00K
$19.69K
~ACHN
Achillion Pharmaceuticals
$13.31M
Oruka Therapeutics
Oct 24, 2012
Director, Ten Percent Owner
Uninformative Buy
123.78K
$42.95M
Exelixis
Director
$19.94M
List of latest transactions for each holding click on a transaction to see Jean Francois Formela's performance on stock

Jean Francois Formela insider profile FAQ

What is the percentage of profitable transactions made by Jean Francois Formela?
The percentage of profitable transactions made by Jean Francois Formela is 10%.
    What is the average return per transaction made by Jean Francois Formela?
    The average return per transaction made by Jean Francois Formela is -52.30%.
      What stocks does Jean Francois Formela hold?
      Jean Francois Formela holds: HZNP, NTLA, SPRO, ~TBIO, IKNA, KRRO, NXTM, EGLTQ, ~ACHN, ORKA, EXEL stocks.
        What was Jean Francois Formela’s latest transaction?
        Jean Francois Formela latest transaction was an Uninformative Buy of $999.99K.
          What was Jean Francois Formela's most profitable transaction?
          Jean Francois Formela’s most profitable transaction was an Informative Sell of NTLA stock on March 22, 2018. The return on the trade was 29.80%.
            What is Jean Francois Formela's role in Horizon Therapeutics?
            Jean Francois Formela's role in Horizon Therapeutics is Director, Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.